FUJIFILM Biosciences’ Brandon Pence on Autologous Cell Variability, Viral Vector Capsid Quality, and the Path to Scalable CGT ManufacturingByFeliza Mirasol,Brandon PenceJuly 27th 2026
Lonza, Engitix Ink ADC License Deal for ECM-Targeted Cancer, Fibrosis TherapiesByFeliza MirasolJuly 21st 2026
Thermo Fisher Scientific’s Paul Jorjorian Discusses Genetic Medicine Diversification, Partnership Trust, and Raw Material Risk in Biopharma DevelopmentByNicholas Jacobus,Paul Jorjorian,Feliza MirasolJuly 16th 2026
Novartis’ Carrie Bracco Says Flexibility in Biomanufacturing is the Most Underaddressed Need for Emerging Biotech CompaniesByNicholas Jacobus,Carrie Bracco,Feliza MirasolJuly 13th 2026
